This announcement is a separate document:
アステラス製薬:アステラス製薬は、欧州連合におけるAvacincaptad Pegol(ACP)の販売承認申請に関する最新情報を提供しました
Astellas Pharma: Astellas Provides Update on Marketing Authorization Application for Avacincaptad Pegol (ACP) in the European Union
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.